NYSE : PFE
Pfizer Inc. — Key statistics
Healthcare · Drug Manufacturers - General · United States
Last price 30.52 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 173.95B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 174.81B |
| Enterprise Value | 226.58B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Nov 6, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 5.70B |
| Shares Outstanding | 5.70B |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 68.11% |
| Float | 5.69B |
Ratios
| Measure | Value |
|---|
| PE Ratio | 40.36 |
| Forward PE | 11.10 |
| PS Ratio | 2.74 |
| Forward PS | 2.86 |
| PB Ratio | 2.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.91 |
| P/OCF Ratio | 13.04 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 52.28 |
| EV / Sales | 3.56 |
| EV / EBITDA | 8.93 |
| EV / EBIT | 12.02 |
| EV / FCF | 20.63 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.27 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | 5.78 |
| Interest Coverage | 6.98 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 5.01% |
| Return on Assets (ROA) | 5.78% |
| Return on Invested Capital (ROIC) | 13.49% |
| Return on Capital Employed (ROCE) | 11.18% |
| Weighted Average Cost of Capital (WACC) | 5.13% |
| Revenue Per Employee | $849,280 |
| Profits Per Employee | $57,787 |
| Employee Count | 75,000 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.49 |
Taxes
| Measure | Value |
|---|
| Income Tax | -164.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +24.42% |
| 50-Day Moving Average | 28.60 |
| 200-Day Moving Average | 26.82 |
| Relative Strength Index (RSI) | 67.70 |
| Average Volume (20 Days) | 30,392,769 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 137.82M |
| Short Previous Month | 155.20M |
| Short % of Shares Out | 2.42% |
| Short % of Float | 2.42% |
| Short Ratio (days to cover) | 4.20 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 63.70B |
| Gross Profit | 47.59B |
| Operating Income | 18.84B |
| Pretax Income | 4.21B |
| Net Income | 4.33B |
| EBITDA | 25.38B |
| EBIT | 18.84B |
| Earnings Per Share (EPS) | $0.76 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 11.70B |
| Total Debt | 63.48B |
| Net Cash | -51.78B |
| Net Cash Per Share | -$9.08 |
| Equity (Book Value) | 85.49B |
| Book Value Per Share | 14.95 |
| Working Capital | 8.71B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 13.40B |
| Capital Expenditures | -2.42B |
| Depreciation & Amortization | 6.54B |
| Net Borrowing | 1.78B |
| Free Cash Flow | 10.99B |
| FCF Per Share | $1.93 |
Margins
| Measure | Value |
|---|
| Gross Margin | 74.72% |
| Operating Margin | 29.58% |
| Pretax Margin | 6.61% |
| Profit Margin | 6.80% |
| EBITDA Margin | 39.85% |
| EBIT Margin | 29.58% |
| FCF Margin | 17.25% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.72 |
| Dividend Yield | 5.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 15 |
| Payout Ratio | 226.35% |
| FCF Payout Ratio | 89.24% |
| Buyback Yield | -0.34% |
| Shareholder Yield | 5.27% |
| Earnings Yield | 2.48% |
| FCF Yield | 6.28% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $29.26 |
| Price Target Difference | -4.60% |
| Analyst Consensus | Hold |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | -4.20% |
| EPS Growth Forecast (3Y) | -8.62% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 1, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.22 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |